EM
No verificado

EMD Serono

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaMedicina - VariosSalud
10/11/2026
Industria
Ciencia
Biotecnología
Farmacéutica
Oncología
Salud
Higiene alimentaria
Medicina - Varios
FDA Approves PIMJETMI® (pimicotinib) for Patients with Tenosynovial Giant Cell Tumor
1.00
10/11/2026
Industria
Ciencia
Biotecnología
Farmacéutica
Oncología
Salud
Higiene alimentaria
Medicina - Varios
FDA Approves PIMJETMI® (pimicotinib) for Patients with Tenosynovial Giant Cell Tumor
1.00
19/10/2026
Oncología
Salud
Ciencia
Farmacéutica
Biotecnología
Mercado de valores
Merck KGaA, Darmstadt, Germany to Acquire Silence Therapeutics, Strengthening Rare Disease Pipeline with Innovative siRNA Asset
1.00
08/07/2026
Industria
Higiene alimentaria
Salud
Farmacéutica
Medicina - Varios
EMD Serono Announces FDA Breakthrough Therapy Designation for Enpatoran in Lupus Patients with Active Skin Manifestations
1.00
24/06/2026
Mercado laboral
Oncología
Salud
Sanidad
Medicina - Varios
Farmacéutica
EMD Serono Announces Healthcare Leadership Changes for Global Commercial Strategy and North America
1.00
23/06/2026
Mercado laboral
Industria
Ciencia
Biotecnología
Cardiología
Sanidad
Farmacéutica
Salud
Merck KGaA, Darmstadt, Germany, Collaborates with Versant Ventures to Launch Saturnus Bio to Advance Treatments for Rare Genetic Cardiomyopathies
1.00
21/05/2026
Oncología
Salud
Medicina - Varios
Sanidad
Farmacéutica
Biotecnología
Industria
Merck KGaA, Darmstadt, Germany, Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer
1.00
06/02/2026
Material médico sanitario
Sanidad
Biotecnología
Farmacéutica
Ir de compras
Salud
Telefonía
Industria
EMD Serono Advances Patient Access to IVF Medicines in the U.S., Aligned with National Health Priorities
1.00

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0